Table 1.
Clinical characteristics of the patients with IPF used in this study
| Characteristics | Freiburg cohort | Siena cohort | Leuven cohort |
|---|---|---|---|
| No. of patients | 62 | 50 | 64 |
| Age (median, range) | 69 (63–75) | 69 ± 11 | 68 ± 9 |
| Gender (%) | |||
| Female | 9 (14.5) | 10 (20.0) | 13 (20.3) |
| male | 53 (85.5) | 40 (80.0) | 51 (79.7) |
| GAP | |||
| Stage I | 17 (27.4) | 14 (28.0) | 25 (39.1) |
| Stage II | 32 (51.6) | 20 (40.0) | 31 (48.4) |
| Stage III | 13 (21.0) | 16 (32.0) | 8 (12.5) |
| Survival status | |||
| Time to death (months) | 18 (6–32) | 14 ± 9 | 12 (7–24) |
| Censored | 17 (27.4) | 19 (38.0) | 40 (62.5) |
Values are presented as median (IQR), mean ± SD or n (%)
GAP gender, age and physiologic variables, IQR interquartile range, SD standard deviation